Switch to:
More From Other Websites
Amicus Reports Additional Positive Data on Fabry Therapy Oct 20 2014
Sanofi and Regeneron Dose Patients in Dupilumab Study Oct 20 2014
Amgen Sues Sanofi and Regeneron over PCSK9 Candidate Oct 20 2014
3 Drugs Stocks Dragging The Industry Down Oct 20 2014
MannKind: Goldman Sachs Sees 'Limited Upside' Oct 20 2014
10:36 am Sanofi-Aventis's Genzyme reports results from two phase III studies added to U.S. Label of... Oct 20 2014
Results from Two Phase III Studies Added to U.S. Label of Genzyme’s Aubagio Oct 20 2014
US FDA Accepts for Review a Biologics License Application for Merck and Sanofi Pasteur’s... Oct 20 2014
Regeneron and Sanofi Announce Start of Phase 3 Study of Dupilumab in Patients with Atopic Dermatitis Oct 20 2014
Two Tribes Go to War: Amgen Sues Regeneron for Patent Infringement Oct 17 2014


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK